Akèy › Ensifizans renn › Missouri
Etid klinik pou Ensifizans renn nan Missouri
6 etid pou Ensifizans renn ap chèche patisipan nan sit nan Missouri.
Vil nan Missouri
Tèks ofisyèl etid la (Anglè)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Clinical Research Consultants, Kansas City
- Kansas City VA Medical Center, Kansas City
- DCI-Rockhill, Kansas City
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
- Washington University in St. Louis, St Louis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT05287945A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
- Research Site, Kansas City
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Aug 14, 2026 · NCT06749457International (Pediatric) Peritoneal Biobank
- Children's Mercy Hospital, Kansas City
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Day – 90 Years · Tout sèks · Mizajou Apr 30, 2026 · NCT01893710Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- Washington University, St Louis
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Mar 24, 2026 · NCT06217302SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- University of Missouri, Columbia
- Saint Louis University, St Louis
- Washington University School of Medicine, St Louis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT06001827Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.